Q3 2020 |
26 |
$53.8M |
+$6.92M |
-$2.75M |
+$4.17M |
WFC, CVX, T, GSKXXXX, LUMNXXXX
|
13F-HR |
11/16/2020, 05:27 PM |
Q2 2020 |
10 |
$56M |
+$1.34M |
-$3.91M |
-$2.58M |
WFC, CVX, T, GSKXXXX, VOD
|
13F-HR |
8/14/2020, 01:15 PM |
Q1 2020 |
11 |
$58.3M |
+$199K |
-$17.7M |
-$17.5M |
WFC, CVX, T, GSKXXXX, VOD
|
13F-HR |
5/15/2020, 01:28 PM |
Q4 2019 |
14 |
$130M |
+$10M |
-$1.95M |
+$8.07M |
WFC, CVX, T, TGT, VZ
|
13F-HR |
2/6/2020, 01:54 PM |
Q3 2019 |
13 |
$116M |
+$1.01M |
-$7.81M |
-$6.8M |
WFC, CVX, T, VOD, GSKXXXX
|
13F-HR |
11/14/2019, 03:56 PM |
Q2 2019 |
12 |
$117M |
+$25.2M |
-$807K |
+$24.4M |
WFC, CVX, T, GSKXXXX, VOD
|
13F-HR |
8/14/2019, 03:57 PM |
Q1 2019 |
12 |
$93M |
$0 |
-$8.99M |
-$8.99M |
WFC, CVX, T, GSKXXXX, VZ
|
13F-HR |
5/15/2019, 12:28 PM |
Q4 2018 |
28 |
$95.7M |
+$35.5K |
-$101K |
-$65.1K |
WFC, CVX, T, GSK, VZ
|
13F-HR |
2/19/2019, 07:19 PM |
Q3 2018 |
37 |
$109M |
+$5.73M |
-$52K |
+$5.68M |
WFC, CVX, T, GSK, TGT
|
13F-HR |
12/6/2018, 01:05 PM |
Q2 2018 |
41 |
$107M |
+$1M |
$0 |
+$1M |
WFC, CVX, GSK, T, TGT
|
13F-HR |
8/20/2018, 02:42 PM |
Q1 2018 |
41 |
$100M |
+$4.37M |
-$111K |
+$4.26M |
WFC, CVX, GSK, VOD, TGT
|
13F-HR |
5/14/2018, 04:29 PM |
Q4 2017 |
43 |
$108M |
$0 |
$0 |
|
WFC, CVX, VZ, TGT, GSK
|
13F-HR |
1/29/2018, 01:04 PM |